52 Week Range
As of on the Mexico Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Genomma Lab Internacional appoints new executive vice president and CFO
HR Ratings affirms rating for Genomma Lab Internacional SAB de CV
Genomma Lab Internacional SAB de CV sells Grupo Marzam for 2.93 bln pesos
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.
Biotechnology & Drugs
Antonio Dovali Jaime no. 70 Piso 2
Colonia Santa Fe
Rodrigo Alonso Herrera Aspra
Chairman of the Board, Independent Director
Chief Executive Officer
Antonio Zamora Galland
Executive Vice President, Chief Financial and Chief Administrative Officer
Executive Vice-President of Global Sales
Alejandro Baston Patino
Vice-President of International and Sales Development
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
(Recasts throughout, updates prices) * Brazil currency dives almost 3 percent, stocks down 3.6 percent * Argentina peso hits fresh all-time low vs dollar * Mexican shares buck gloom, rise 0.3 percent By Susan Mathew March 27 (Reuters) - Latin American shares and currencies...
S&P Dow Jones Indices (S&P DJI) said on Friday that shares in bank Banco del Bajio and pharmaceutical company Genomma Lab would enter Mexico's leading share index from Sept. 24.
GMexico Transportes , the rail unit of Mexican miner and infrastructure company Grupo Mexico, will be added to the country's benchmark S&P/BMV IPC stock index starting on March 20, S&P Dow Jones Indices said on Friday.
Private equity fund Nexxus Capital said on Monday it plans to invest $350 million over 12 to 18 months in small- and medium-sized firms with high exposure to middle-class consumers in Mexico, Spain and Portugal.
Many Mexican companies, from dominant telecom provider America Movil to bottler Femsa, cut debts in the second quarter, helped by a stronger peso, although they are unlikely to rush to return money to investors or increase investment.
Brazilian stocks rose on Tuesday, lifted by corporate news and quarterly reports, while Mexican stocks bounced back from a four-day slump after earnings reports disappointed some investors. Mexico's S&P/BMV IPC stock index ticked up 0.36 percent to 51,195 points. The index...
Mexico's competition regulator Cofece said on Wednesday it had opened an investigation into possible "absolute monopolistic practices" in the country's medicines market.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.